Gap CO2 in Septic Patient to Predict Cardiomyopathy Septic
1 other identifier
observational
98
1 country
1
Brief Summary
the investigators included 98 patients admitted for sepsis and septic shock (68.4% men, 31.6% women) with an average age of 60.42 years ± 15.13, ranging from 21 to 96 years. The average length of hospital stay was 7.53 days. The most noted medical histories were diabetes (38.8%), hypertension (28.6%), and renal insufficiency (17.1%). Regarding laboratory findings: the mean white blood cell count was 15,985.16 cells/mm³, the mean C-reactive protein (CRP) level was 227.69 mg/L, and the mean procalcitonin level was 50.43 µg/L. In terms of blood gas analysis: the mean lactate level was 3.67 mmol/L, and the mean PCO2 gap (DELTAPCO2) was 4.85. All our patients were continuously monitored by pulse wave analysis: the mean cardiac output was 5.69 L/min, and the mean cardiac index was 4.14 L/s/m² All our patients underwent an echocardiogram, which is a routine examination in our department and is performed at the patient's bedside. The average left ventricular ejection fraction (LVEF) was 51.73%, and the average subaortic peak velocity (ITV) was 14.66 cm. Subsequently. the investigators examined the clinical and paraclinical profile of patients with septic cardiomyopathy. the investigators identified 19 patients with this condition, while 79 patients did not exhibit cardiac involvement. The percentage was significantly higher in the population with cardiac involvement, accounting for 28.3%. Among the patients with cardiac involvement, 76.5% had a PCO2 gap (DELTAPCO2) ≥ 6 mmHg, a significantly reduced cardiac output with an average of 3.3 L/min, and a predominantly low cardiac index, with 64.3% having an index \< 2.2 L/min/m². The mortality rate was significantly increased at 73.7%.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2023
CompletedFirst Submitted
Initial submission to the registry
March 3, 2024
CompletedFirst Posted
Study publicly available on registry
March 22, 2024
CompletedMarch 22, 2024
March 1, 2024
10 months
March 3, 2024
March 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
gapCO2
significative in cardiomyopathy septic
10 mounths
Study Arms (2)
Myocardial Dysfunction
No Myocardial Dysfunction
Interventions
Eligibility Criteria
We included patients diagnosed with sepsis/septic shock admitted at various points in time to the intensive care units of the Mohammed VI University Hospital in Oujda.
You may qualify if:
- Patients admitted to the intensive care unit
- sepsis or septic shock
- at least one echocardiogram and were monitored by pulse wave contour analysis
- stay of 72 hours in the intensive care unit
You may not qualify if:
- Patients without sepsis or septic shock.
- Patients with COVID-19.
- Patients who died within 48 hours of hospitalization.
- Cases with incomplete medical records or patients not monitored.
- Patient with pre-existing cardiac conditions.
- post-operative patients from cardiac and thoracic surgeries.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
younes Oujidi
Berkane, 9999, Morocco
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- doctor
Study Record Dates
First Submitted
March 3, 2024
First Posted
March 22, 2024
Study Start
January 1, 2023
Primary Completion
October 30, 2023
Study Completion
October 30, 2023
Last Updated
March 22, 2024
Record last verified: 2024-03